Acknowledgement
The authors would like to thank Sungwon Kim, MD, Jun Tae Kim, and Kyunghwa Han, PhD, from the Department of Radiology, Yonsei University College of Medicine, for their assistance in data collection and preparation (S.K. and J.K.) and statistical analysis (K.H.).
References
- Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, Abecassis MM, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018;68:723-750 https://doi.org/10.1002/hep.29913
- European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2018;69:182-236 https://doi.org/10.1016/j.jhep.2018.03.019
- Omata M, Cheng AL, Kokudo N, Kudo M, Lee JM, Jia J, et al. Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update. Hepatol Int 2017;11:317-370 https://doi.org/10.1007/s12072-017-9799-9
- Korean Liver Cancer Study Group and Korean National Cancer Center. 2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol 2015;16:465-522 https://doi.org/10.3348/kjr.2015.16.3.465
- Kudo M, Trevisani F, Abou-Alfa GK, Rimassa L. Hepatocellular carcinoma: therapeutic guidelines and medical treatment. Liver Cancer 2016;6:16-26 https://doi.org/10.1159/000449343
- Kim YY, An C, Kim DY, Aljoqiman KS, Choi JY, Kim MJ. Failure of hepatocellular carcinoma surveillance: inadequate echogenic window and macronodular parenchyma as potential culprits. Ultrasonography 2019;38:311-320 https://doi.org/10.14366/usg.18051
- Rhee H, Kim MJ, Park YN, An C. A proposal of imaging classification of intrahepatic mass-forming cholangiocarcinoma into ductal and parenchymal types: clinicopathologic significance. Eur Radiol 2019;29:3111-3121 https://doi.org/10.1007/s00330-018-5898-9
- Kim YY, Park MS, Aljoqiman KS, Choi JY, Kim MJ. Gadoxetic acid-enhanced magnetic resonance imaging: hepatocellular carcinoma and mimickers. Clin Mol Hepatol 2019;25:223-233 https://doi.org/10.3350/cmh.2018.0107
- Han S, Choi JI, Park MY, Choi MH, Rha SE, Lee YJ. The diagnostic performance of liver MRI without intravenous contrast for detecting hepatocellular carcinoma: a casecontrolled feasibility study. Korean J Radiol 2018;19:568-577 https://doi.org/10.3348/kjr.2018.19.4.568
- Murakami T, Tsurusaki M. Hypervascular benign and malignant liver tumors that require differentiation from hepatocellular carcinoma: key points of imaging diagnosis. Liver Cancer 2014;3:85-96 https://doi.org/10.1159/000343864
- Chernyak V, Fowler KJ, Kamaya A, Kielar AZ, Elsayes KM, Bashir MR, et al. Liver imaging reporting and data system (LI-RADS) version 2018: imaging of hepatocellular carcinoma in at-risk patients. Radiology 2018;289:816-830 https://doi.org/10.1148/radiol.2018181494
- Cerny M, Bergeron C, Billiard JS, Murphy-Lavallee J, Olivie D, Berube J, et al. LI-RADS for MR imaging diagnosis of hepatocellular carcinoma: performance of major and ancillary features. Radiology 2018;288:118-128 https://doi.org/10.1148/radiol.2018171678
- Elsayes KM, Kielar AZ, Elmohr MM, Chernyak V, Masch WR, Furlan A, et al. White paper of the Society of Abdominal Radiology hepatocellular carcinoma diagnosis disease-focused panel on LI-RADS v2018 for CT and MRI. Abdom Radiol (NY) 2018;43:2625-2642 https://doi.org/10.1007/s00261-018-1744-4
- Cerny M, Chernyak V, Olivie D, Billiard JS, Murphy-Lavallee J, Kielar AZ, et al. LI-RADS version 2018 ancillary features at MRI. Radiographics 2018;38:1973-2001 https://doi.org/10.1148/rg.2018180052
- Zech CJ, Ba-Ssalamah A, Berg T, Chandarana H, Chau GY, Grazioli L, et al. Consensus report from the 8th International Forum for Liver Magnetic Resonance Imaging. Eur Radiol 2019 Aug 5 [Epub ahead of print]. https://doi.org/10.1007/s00330-019-06369-4
- Li J, Wang J, Lei L, Yuan G, He S. The diagnostic performance of gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced multi-detector computed tomography in detecting hepatocellular carcinoma: a metaanalysis of eight prospective studies. Eur Radiol 2019 Jun 27 [Epub ahead of print]. https://doi.org/10.1007/s00330-019-06294-6
- Korean Society of Abdominal Radiology. Diagnosis of hepatocellular carcinoma with gadoxetic acid-enhanced MRI: 2016 consensus recommendations of the Korean Society of Abdominal Radiology. Korean J Radiol 2017;18:427-443 https://doi.org/10.3348/kjr.2017.18.3.427
- Imai Y, Katayama K, Hori M, Yakushijin T, Fujimoto K, Itoh T, et al. Prospective comparison of Gd-EOB-DTPA-enhanced MRI with dynamic CT for detecting recurrence of HCC after radiofrequency ablation. Liver Cancer 2017;6:349-359 https://doi.org/10.1159/000481416
- Roberts LR, Sirlin CB, Zaiem F, Almasri J, Prokop LJ, Heimbach JK, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology 2018;67:401-421 https://doi.org/10.1002/hep.29487
- Hajian-Tilaki K. Sample size estimation in diagnostic test studies of biomedical informatics. J Biomed Inform 2014;48:193-204 https://doi.org/10.1016/j.jbi.2014.02.013
- Pencina MJ, D'Agostino RB Sr, D'Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med 2008;27:157-172; discussion 207-212 https://doi.org/10.1002/sim.2929
- Liu X, Jiang H, Chen J, Zhou Y, Huang Z, Song B. Gadoxetic acid disodium-enhanced magnetic resonance imaging outperformed multidetector computed tomography in diagnosing small hepatocellular carcinoma: a meta-analysis. Liver Transpl 2017;23:1505-1518 https://doi.org/10.1002/lt.24867
- Choi SH, Lee SS, Kim SY, Park SH, Park SH, Kim KM, et al. Intrahepatic cholangiocarcinoma in patients with cirrhosis: differentiation from hepatocellular carcinoma by using gadoxetic acid-enhanced MR imaging and dynamic CT. Radiology 2017;282:771-781 https://doi.org/10.1148/radiol.2016160639
- Chen N, Motosugi U, Morisaka H, Ichikawa S, Sano K, Ichikawa T, et al. Added value of a gadoxetic acid-enhanced hepatocyte-phase image to the LI-RADS system for diagnosing hepatocellular carcinoma. Magn Reson Med Sci 2016;15:49-59 https://doi.org/10.2463/mrms.2014-0149
- Joo I, Lee JM, Lee DH, Ahn SJ, Lee ES, Han JK. Liver imaging reporting and data system v2014 categorization of hepatocellular carcinoma on gadoxetic acid-enhanced MRI: comparison with multiphasic multidetector computed tomography. J Magn Reson Imaging 2017;45:731-740 https://doi.org/10.1002/jmri.25406
- Kim YN, Song JS, Moon WS, Hwang HP, Kim YK. Intraindividual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Acta Radiol 2018;59:639-648 https://doi.org/10.1177/0284185117728534
- Fraum TJ, Tsai R, Rohe E, Ludwig DR, Salter A, Nalbantoglu I, et al. Differentiation of hepatocellular carcinoma from other hepatic malignancies in patients at risk: diagnostic performance of the liver imaging reporting and data system version 2014. Radiology 2018;286:158-172 https://doi.org/10.1148/radiol.2017170114
- Kim MJ, Lee S, An C. Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma. Eur Radiol 2019;29:5101-5110 https://doi.org/10.1007/s00330-019-06030-0
- Kim YY, Kim MJ, Kim EH, Roh YH, An C. Hepatocellular carcinoma versus other hepatic malignancy in cirrhosis: performance of LI-RADS version 2018. Radiology 2019;291:72-80 https://doi.org/10.1148/radiol.2019181995
- Lee HS, Kim MJ, An C. How to utilize LR-M features of the LI-RADS to improve the diagnosis of combined hepatocellular-cholangiocarcinoma on gadoxetate-enhanced MRI? Eur Radiol 2019;29:2408-2416 https://doi.org/10.1007/s00330-018-5893-1
- Ludwig DR, Fraum TJ, Cannella R, Ballard DH, Tsai R, Naeem M, et al. Hepatocellular carcinoma (HCC) versus non-HCC: accuracy and reliability of liver imaging reporting and data system v2018. Abdom Radiol (NY) 2019;44:2116-2132 https://doi.org/10.1007/s00261-019-01948-x
- Ronot M, Fouque O, Esvan M, Lebigot J, Aube C, Vilgrain V. Comparison of the accuracy of AASLD and LI-RADS criteria for the non-invasive diagnosis of HCC smaller than 3 cm. J Hepatol 2018;68:715-723 https://doi.org/10.1016/j.jhep.2017.12.014
- Becker AS, Barth BK, Marquez PH, Donati OF, Ulbrich EJ, Karlo C, et al. Increased interreader agreement in diagnosis of hepatocellular carcinoma using an adapted LI-RADS algorithm. Eur J Radiol 2017;86:33-40 https://doi.org/10.1016/j.ejrad.2016.11.004
- Barth BK, Donati OF, Fischer MA, Ulbrich EJ, Karlo CA, Becker A, et al. Reliability, validity, and reader acceptance of LIRADS-An in-depth analysis. Acad Radiol 2016;23:1145-1153 https://doi.org/10.1016/j.acra.2016.03.014
- Fowler KJ, Tang A, Santillan C, Bhargavan-Chatfield M, Heiken J, Jha RC, et al. Interreader reliability of LI-RADS version 2014 algorithm and imaging features for diagnosis of hepatocellular carcinoma: a large international multireader study. Radiology 2018;286:173-185 https://doi.org/10.1148/radiol.2017170376
Cited by
- Characteristics of Recent Articles Published in the Korean Journal of Radiology Based on the Citation Frequency vol.21, pp.12, 2020, https://doi.org/10.3348/kjr.2020.1322
- Liver imaging reporting and data system category M: A systematic review and meta‐analysis vol.40, pp.6, 2020, https://doi.org/10.1111/liv.14420
- Clinical Application of Liver Imaging Reporting and Data System for Characterizing Liver Neoplasms: A Meta-Analysis vol.11, pp.2, 2019, https://doi.org/10.3390/diagnostics11020323
- Enhancing capsule in hepatocellular carcinoma: intra-individual comparison between CT and MRI with extracellular contrast agent vol.102, pp.12, 2019, https://doi.org/10.1016/j.diii.2021.06.004